Abstract |
The role of interleukin 25 (IL-25) in a number of human diseases still has not been extensively studied, here we attempt to evaluate the role of recombinant IL-25 (rIL-25) in the development of dextran sulfate sodium (DSS)-induced experimental colitis. Acute colitis was induced in female C57BL/6 mice by oral administration of 2.5% DSS in drinking water ad libitum. At the same time as the start of DSS exposure, mice were injected intraperitoneally with 0.4 microg of rIL-25 or PBS. Then disease activity index (DAI), histological changes and survival rate were observed. The levels of IL-17, IL-23, and TGF-beta1 in colon tissues were determined by ELISA, and the production of IL-17 by CD4(+)/CD8(+) T cells was detected by intracellular flow cytometry. In contrast to the DSS treated mice, DSS + rIL-25 treated mice displayed a lower DAI, limited histological changes and prolonged survival. The levels of IL-23 and TGF-beta1 were significantly elevated in the DSS + rIL-25 treated mice compared to the DSS treated mice. There was no significant difference in the production of IL-17 in colon tissues and CD4(+)/CD8(+) T cells between the DSS + rIL-25 treated mice and DSS treated mice. Our findings suggest the role of IL-25 in inhibiting development and progression of acute colitis in DSS-induced mouse colitis model.
|
Authors | S S Salum Mchenga, Danan Wang, Cheng Li, Fengping Shan, Changlong Lu |
Journal | Cellular & molecular immunology
(Cell Mol Immunol)
Vol. 5
Issue 6
Pg. 425-31
(Dec 2008)
ISSN: 2042-0226 [Electronic] China |
PMID | 19118508
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-17
- Interleukin-23
- Recombinant Proteins
- Transforming Growth Factor beta1
- Dextran Sulfate
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(drug effects, immunology)
- CD8-Positive T-Lymphocytes
(drug effects, immunology)
- Colitis
(drug therapy, pathology)
- Dextran Sulfate
- Disease Progression
- Female
- Flow Cytometry
- Interleukin-17
(metabolism, pharmacology, therapeutic use)
- Interleukin-23
(metabolism)
- Kaplan-Meier Estimate
- Mice
- Mice, Inbred C57BL
- Recombinant Proteins
(pharmacology, therapeutic use)
- Transforming Growth Factor beta1
(metabolism)
|